Abstract 2849: Tie2-expressing macrophages (TEM) depletion may enhance the clinical efficacy of combretastatin A-4-phosphate (CA-4-P)

MLA

Silvia Nucera, et al. “Abstract 2849: Tie2-Expressing Macrophages (TEM) Depletion May Enhance the Clinical Efficacy of Combretastatin A-4-Phosphate (CA-4-P).” Cancer Research, vol. 71, Apr. 2011, p. 2849. EBSCOhost, https://doi.org/10.1158/1538-7445.am2011-2849.

APA

Silvia Nucera, Daniela Biziato, Claire E. Lewis, Ferdinando Pucci, Welford F. Abigail, Michele De Palma, Gillian M. Tozer, Matthew Fisher, Seth B. Coffelt, Clelia Di Serio, & Luigi Naldini. (2011). Abstract 2849: Tie2-expressing macrophages (TEM) depletion may enhance the clinical efficacy of combretastatin A-4-phosphate (CA-4-P). Cancer Research, 71, 2849. https://doi.org/10.1158/1538-7445.am2011-2849

Chicago

Silvia Nucera, Daniela Biziato, Claire E. Lewis, Ferdinando Pucci, Welford F. Abigail, Michele De Palma, Gillian M. Tozer, et al. 2011. “Abstract 2849: Tie2-Expressing Macrophages (TEM) Depletion May Enhance the Clinical Efficacy of Combretastatin A-4-Phosphate (CA-4-P).” Cancer Research 71 (April): 2849. doi:10.1158/1538-7445.am2011-2849.